Rezolute (RZLT) Competitors $2.89 -0.14 (-4.62%) Closing price 04:00 PM EasternExtended Trading$3.08 +0.20 (+6.75%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RZLT vs. LENZ, CRON, PRTA, AVBP, ORGO, CVAC, GHRS, NUVB, CRMD, and IMNMShould you be buying Rezolute stock or one of its competitors? The main competitors of Rezolute include LENZ Therapeutics (LENZ), Cronos Group (CRON), Prothena (PRTA), ArriVent BioPharma (AVBP), Organogenesis (ORGO), CureVac (CVAC), GH Research (GHRS), Nuvation Bio (NUVB), CorMedix (CRMD), and Immunome (IMNM). These companies are all part of the "pharmaceutical products" industry. Rezolute vs. LENZ Therapeutics Cronos Group Prothena ArriVent BioPharma Organogenesis CureVac GH Research Nuvation Bio CorMedix Immunome LENZ Therapeutics (NASDAQ:LENZ) and Rezolute (NASDAQ:RZLT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, community ranking, media sentiment, earnings, analyst recommendations, risk, profitability and valuation. Which has stronger valuation & earnings, LENZ or RZLT? LENZ Therapeutics is trading at a lower price-to-earnings ratio than Rezolute, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLENZ TherapeuticsN/AN/A-$124.65M-$4.77-5.54RezoluteN/AN/A-$68.46M-$1.22-2.37 Is LENZ or RZLT more profitable? LENZ Therapeutics' return on equity of -58.48% beat Rezolute's return on equity.Company Net Margins Return on Equity Return on Assets LENZ TherapeuticsN/A -58.48% -55.50% Rezolute N/A -70.27%-62.41% Does the media prefer LENZ or RZLT? In the previous week, LENZ Therapeutics had 38 more articles in the media than Rezolute. MarketBeat recorded 41 mentions for LENZ Therapeutics and 3 mentions for Rezolute. LENZ Therapeutics' average media sentiment score of 0.55 beat Rezolute's score of 0.48 indicating that LENZ Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LENZ Therapeutics 8 Very Positive mention(s) 3 Positive mention(s) 14 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Rezolute 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, LENZ or RZLT? LENZ Therapeutics has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Comparatively, Rezolute has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500. Does the MarketBeat Community prefer LENZ or RZLT? Rezolute received 60 more outperform votes than LENZ Therapeutics when rated by MarketBeat users. However, 100.00% of users gave LENZ Therapeutics an outperform vote while only 80.00% of users gave Rezolute an outperform vote. CompanyUnderperformOutperformLENZ TherapeuticsOutperform Votes12100.00% Underperform VotesNo VotesRezoluteOutperform Votes7280.00% Underperform Votes1820.00% Do analysts recommend LENZ or RZLT? LENZ Therapeutics presently has a consensus price target of $41.67, indicating a potential upside of 57.65%. Rezolute has a consensus price target of $24.38, indicating a potential upside of 743.43%. Given Rezolute's higher probable upside, analysts plainly believe Rezolute is more favorable than LENZ Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LENZ Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13Rezolute 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 Do institutionals and insiders believe in LENZ or RZLT? 54.3% of LENZ Therapeutics shares are held by institutional investors. Comparatively, 83.0% of Rezolute shares are held by institutional investors. 38.4% of LENZ Therapeutics shares are held by insiders. Comparatively, 18.4% of Rezolute shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryRezolute beats LENZ Therapeutics on 7 of the 13 factors compared between the two stocks. Remove Ads Get Rezolute News Delivered to You Automatically Sign up to receive the latest news and ratings for RZLT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RZLT vs. The Competition Export to ExcelMetricRezolutePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$179.49M$7.06B$5.72B$8.30BDividend YieldN/A2.72%4.55%4.02%P/E Ratio-2.437.2724.6619.31Price / SalesN/A230.97392.8595.27Price / CashN/A65.6738.1634.64Price / Book1.786.667.134.47Net Income-$68.46M$142.13M$3.20B$247.07M7 Day Performance-12.67%3.38%1.85%3.22%1 Month Performance-29.59%3.22%6.21%-2.69%1 Year Performance55.71%-4.22%15.40%4.64% Rezolute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RZLTRezolute2.5868 of 5 stars$2.89-4.6%$24.38+743.4%+51.5%$174.95MN/A-2.3740High Trading VolumeLENZLENZ Therapeutics2.1532 of 5 stars$26.66+0.6%$41.67+56.3%+64.6%$733.18MN/A-5.59110Earnings ReportAnalyst RevisionNews CoverageCRONCronos Group1.4605 of 5 stars$1.88+5.0%$3.00+59.6%-28.0%$719.16M$117.62M-14.46450News CoveragePRTAProthena2.9718 of 5 stars$13.34+2.9%$55.00+312.3%-48.5%$718.05M$135.16M-5.80130Positive NewsAVBPArriVent BioPharma1.6027 of 5 stars$20.21+3.5%$39.00+93.0%+10.6%$687.46MN/A-7.8640Upcoming EarningsAnalyst RevisionNews CoverageORGOOrganogenesis2.9551 of 5 stars$5.42+11.1%$5.50+1.5%+107.7%$687.41M$482.04M-90.33950News CoverageCVACCureVac3.4481 of 5 stars$3.00+3.8%$10.00+233.3%-1.6%$671.64M$543.28M5.45880News CoverageGap UpGHRSGH Research2.3562 of 5 stars$12.88+3.0%$30.86+139.6%+19.6%$670.12MN/A-16.3010NUVBNuvation Bio2.5619 of 5 stars$1.96+3.4%$8.33+326.3%-15.4%$662.12M$7.87M-0.9060CRMDCorMedix2.0165 of 5 stars$10.77-1.3%$16.00+48.6%+174.7%$653.49M$12.26M-13.3030Earnings ReportAnalyst ForecastOptions VolumeNews CoverageGap DownIMNMImmunome1.655 of 5 stars$8.15-0.4%$25.50+212.9%-66.5%$650.18M$10.13M-1.0040Earnings ReportUpcoming EarningsAnalyst Revision Remove Ads Related Companies and Tools Related Companies LENZ Alternatives CRON Alternatives PRTA Alternatives AVBP Alternatives ORGO Alternatives CVAC Alternatives GHRS Alternatives NUVB Alternatives CRMD Alternatives IMNM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RZLT) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rezolute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rezolute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RZLT Stock Free RZLT Stock Alerts